Skip to main content
SpringerLink
Log in

Grapefruit Juice-Drug Interaction Issues

  • Chapter
Handbook of Drug-Nutrient Interactions

Part of the book series: Nutrition and Health ((NH))

Abstract

Medications and food are often taken together. Linking drug administration to a regular event like a meal can improve the patient’s adherence to the treatment regimen, especially in the elderly (1). However, concomitant drug and food intake create the opportunity for an interaction that may change (increase or decrease) drug benefit or toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Haynes R, Sackett D, Gibson E. Improvements of medication compliance in uncontrolled hypertension. Lancet 1976; 1: 1256–1258.

    Google Scholar 

  2. Bailey DG, Spence JD, Edgar B, Bayliff CD, Arnold JMO. Ethanol enhances the hemodynamic effects of felodipine. Clin Investig Med 1989; 12: 357–362.

    CAS  Google Scholar 

  3. Bailey DG, Arnold JMO, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998; 46: 101–110.

    Article  CAS  Google Scholar 

  4. Bailey DG, Spence JD, Munoz C, Arnold JMO. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991; 337: 268–269.

    Article  CAS  Google Scholar 

  5. Edgar B, Regardh CG, Johnsson G, et al. Felodipine kinetics in healthy man. Clin Pharmacol Ther 1985; 38: 205–211.

    Article  CAS  Google Scholar 

  6. Blychert E, Edgar B, Elmfeldt D, Hedner T. A population study of the pharmacokinetics of felodipine. Br J Clin Pharmacol 1991; 31: 15–24.

    Article  CAS  Google Scholar 

  7. Regardh CG, Baarnhielm C, Edgar B, Hoffman KJ. Pharmacokinetics and biotransformation of 1,4- dihydropyridine calcium antagonists. Prog Drug Metab 1990; 12: 41–86.

    CAS  Google Scholar 

  8. Guengerich FP, Brian WR, Iwasaki M, Sari MA, Baarnhielm C, Berntsson P. Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P450IIIA4. J Med Chem 1991; 34: 1834–1844.

    Article  Google Scholar 

  9. Bailey DG, Bend JR, Arnold JMO, Tran LT, Spence JD. Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Clin Pharmacol Ther 1996; 60: 25–33.

    Article  CAS  Google Scholar 

  10. Guengerich FP. Cytochrome P-450 3A4; regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 1999; 39: 1–17.

    Article  CAS  Google Scholar 

  11. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 2000; 38: 41–57.

    Article  CAS  Google Scholar 

  12. Kolars JC, Schmiedlin-Rem P, Schuetz JD, Fang C, Watkins PB. Identification of rifampicin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 1992; 90: 1871–1878.

    Article  CAS  Google Scholar 

  13. Lown KS, Kolars JC, Thummel KE, et al. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel–lack of prediction by the erythromycin breath test. Drug Metab Dispos 1994; 22: 947–55.

    CAS  Google Scholar 

  14. Lundahl J, Regardh CG, Edgar B, Johnsson G. Effects of grapefruit juice ingestion-pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol 1997; 52: 139–45.

    Article  CAS  Google Scholar 

  15. Lown KS, Bailey DG, Fontana RJ, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997; 99: 2545–53.

    Article  CAS  Google Scholar 

  16. Lundahl J, Regardh CG, Edgar B, Johnsson G. Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur J Clin Pharmacol 1995; 49: 61–7.

    Article  CAS  Google Scholar 

  17. Takanaga H, Ohnishi A, Murakami H, et al. Relationship between time after intake of grapefruit juice and the effect on the pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clin Pharmacol Ther 2000; 67: 201–14.

    Article  CAS  Google Scholar 

  18. Lilja JJ, Kivisto KT, Neuvonen PJ. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Clin Pharmacol Ther 2000; 68: 384–90.

    Article  CAS  Google Scholar 

  19. Nagy J, Schipper HG, Koopmans RP, Butter JJ, Van Boxel CJ, Kager PA. Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. Am J Trop Med Hyg 2002; 66: 260–263.

    CAS  Google Scholar 

  20. van Agtmael MA, Gupta V, van der Wosten TH, Rutten JP, van Boxtel CJ. Grapefruit juice increases the bioavailability of artemether. Eur J Clin Pharmacol 1999; 55: 405–410.

    Article  Google Scholar 

  21. Kanazawa S, Ohkubo T, Sugawara K. The effects of grapefruit juice on the pharmacokinetics of erythromycin. Eur J Clin Pharmacol 2001; 56: 799–803.

    Article  CAS  Google Scholar 

  22. Charbit B, Becquemont L, Lepere B, Peytavin G, Funck-Bretano C. Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine. Clin Pharmacol Ther 2002; 72: 514–523.

    Article  CAS  Google Scholar 

  23. Castro N, Jung H, Medina R, Gonzalez-Esquivel D, Lopez M, Sotelo J. Interaction between grapefruit juice and praziquantel in humans. Antimicrob Agents Chemother 2002; 46: 1614–1616.

    Article  CAS  Google Scholar 

  24. Kupferschmidt HH, Fattinger KE, Ha HR, Follath F, Krahenbuhl S. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol 1998; 45: 355–359.

    Article  CAS  Google Scholar 

  25. Varis T, Kivisto KT, Neuvonen PJ. Grapefruit juice can increase the plasma concentrations of oral methylprednisolone. Eur J Clin Pharmacol 2000; 56: 489–493.

    Article  CAS  Google Scholar 

  26. Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clin Pharmacol Ther 1999; 66: 118–127.

    CAS  Google Scholar 

  27. Kantola T, Kivisto KT, Neuvonen PJ. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 1998; 63: 397–402.

    Article  CAS  Google Scholar 

  28. Rogers JD, Zhao J, Liu L, Amin RD, et al. Grapefruit juice has minimal effects on plasma concentrations of Lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Clin Pharmacol Ther 1999; 66: 358–366.

    Article  CAS  Google Scholar 

  29. Bailey DG, Dresser GK. Grapefruit juice - lovastatin interaction. (Letter). Clin Pharmacol Ther 2000; 67: 690.

    CAS  Google Scholar 

  30. Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther 1998; 64: 477–483.

    Article  CAS  Google Scholar 

  31. Libersa CC, Brique SA, Motte KB et al. Dramatic inhibition of amiodarone metabolism induced by grapefruit juice. Br J Clin Pharmacol 2000; 49: 373–378.

    Article  CAS  Google Scholar 

  32. Smith Kline Beecham Pharma. Coreg Product Monograph. Oakville, Ontario, 1999.

    Google Scholar 

  33. Bailey DG, Arnold JMO, Bend JR, Tran LT, Spence JD. Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation. Br J Clin Pharmacol 1995; 40: 135–140.

    CAS  Google Scholar 

  34. Edgar B, Bailey DG, Bergstrand R, Johnsson G, Regardh CG. Acute effects of drinking grapefruit juice on the pharmacokinetics and pharmacodyanmics of felodipine—and its potential clinical relevance. Eur J Clin Pharmacol 1992; 42: 313–317.

    Article  CAS  Google Scholar 

  35. Bailey DG, Arnold JMO, Munoz C, Spence JD. Grapefruit juice-felodipine interaction: mechanism, predictability and effect of naringin. Clin Pharmacol Ther 1993; 53: 637–642.

    Article  CAS  Google Scholar 

  36. Bailey DG, Kreeft JH, Munoz C, Freeman JD, Bend JR. Grapefruit juice-felodipine interaction: effect of naringin and 6’,7’-dihydroxybergamottin in humans. Clin Pharmacol Ther 1998; 64: 248–256.

    Article  CAS  Google Scholar 

  37. Dresser GK, Bailey DG, Carruthers SG. Grapefruit juice-felodipine interaction in the elderly. Clin Pharmacol Ther 2000; 68: 28–34.

    Article  CAS  Google Scholar 

  38. Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther 2000; 68: 468–477.

    Article  CAS  Google Scholar 

  39. Malhotra S, Bailey DG, Paine MF, Watkins PB. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of the furanocoumarins. Clin Pharmacol Ther 2001; 69: 14–23.

    Article  CAS  Google Scholar 

  40. Rashid J, McKinstry, Renwick AG, Dirnhuber M, Waller DG, George CF. Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. Br J Clin Pharmacol 1993; 36: 460–463.

    Article  CAS  Google Scholar 

  41. Rashid TJ, Martin U, Clarke H, Waller DG, Renwick AG, George CF. Factors affecting the absolute bioavailability of nifedipine. Br J Clin Pharmacol 1995; 40: 51–58.

    Article  CAS  Google Scholar 

  42. Sigush H, Hippius M, Henschel L, Kaufmann K, Hoffmann A. Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation. Pharmazie 1994; 49: 522–524.

    Google Scholar 

  43. Fuhr U, Maier-Bruggemann A, Blume H, et al. Grapefruit juice increases oral nimodipine bioavailability. Int J Clin Pharmacol Ther 1998; 36: 126–132.

    CAS  Google Scholar 

  44. Uno T, Ohkubo T, Sugawara K, Higashiyama A, Motomura S, Ishizaki T. Effect of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site. Eur J Clin Pharmacol 2000; 56: 643–649.

    Article  CAS  Google Scholar 

  45. Bailey DG, Arnold JMO, Strong HA, Munoz C, Spence JD. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther 1993; 54: 589–594.

    Article  CAS  Google Scholar 

  46. Soons PA, Vogels BAPM, Roosemalen MCM, et al. Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in man. Clin Pharmacol Ther 1991; 50: 394–403.

    Article  CAS  Google Scholar 

  47. Bailey DG, Munoz C, Arnold JMO, Strong HA, Spence JD. Grapefruit juice and naringin interaction with nitrendipine. (Abstract). Clin Pharmacol Ther 1992; 51: 156.

    Google Scholar 

  48. Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, Hering U, Bulitta-Schreiner P, Sorgel F, Fuhr U. Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin Pharmacol Ther 2002; 71: 21–29.

    Article  CAS  Google Scholar 

  49. Zaidenstein R, Dishi V, Gips M, Soback S, Cohen N, Weissgarten J, Blatt A, Golik A. The effect of grapefruit juice on the pharmacokinetics of orally administered verapamil. Eur J Clin Pharmacol 1998; 54: 337–340.

    Article  CAS  Google Scholar 

  50. Ho PC, Ghose K, Saville D, Wanwimolruk S. Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers. Eur J Clin Pharmacol 2000; 56: 693–698.

    Article  CAS  Google Scholar 

  51. Fuhr U, Muller-Peltzer H, Kern R, Lopez-Rojas R, Junemann M, Harder S, Staib AH. Effects of grapefruit juice and smoking on verapamil concentrations in steady state. Eur J Clin Pharmacol 2002; 58: 45–53.

    Article  CAS  Google Scholar 

  52. Lilja JJ, Kivisto KT, Backman JT, Lamberg TS, Neuvonen PJ. Grapefruit juice substantially increases plasma concentrations of buspirone. Clin Pharmacol Ther 1998; 64: 655–660.

    Article  CAS  Google Scholar 

  53. Garg SJ, Kumar N, Bhargava VK, Prabhakar SK. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther 1998; 64: 286–288.

    Article  CAS  Google Scholar 

  54. Ozedemir M, Aktan Y, Boydag BS, Cingi MI, Musmul A. Interaction between grapefruit juice and diazepam in humans. Eur J Drug Metab Pharmacokinet 1998; 23: 55–59

    Article  Google Scholar 

  55. Kupferschmidt HHT, Ha HR, Ziegler WH, Meir PJ, Krahenbuhl S. Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 1995; 58: 20–28.

    Article  CAS  Google Scholar 

  56. Andersen V, Pedersen N, Larsen NE, Sonne J, Larsen S. Intestinal first pass metabolism of midazolam in liver cirrhosis–effect of grapefruit juice. Br J Clin Pharmacol 2002; 54: 120–124.

    Article  CAS  Google Scholar 

  57. Ebert U, Oertel R, Kirch W. Influence of grapefruit juice on scopolamine pharmacokinetics and pharmacodynamics in healthy male and female subjects. Int J Clin Pharmacol Ther 2000; 38: 523–531.

    Article  CAS  Google Scholar 

  58. Lee AJ, Chan WK, Harralson AF, Buffum J, Bui BC. The effects of grapefruit juice on sertraline metabolism: an in vitro and in vivo study. Clin Ther 1999; 21: 1890–1899.

    Article  CAS  Google Scholar 

  59. Hukkinen SK, Varhe A, Olkkola KT, Neuvonen PJ. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin Pharmacol Ther 1995; 58: 127–123.

    Article  CAS  Google Scholar 

  60. Lilja JJ, Kivisto KT, Backman JT, Neuvonen PJ. Effect of grapefruit juice dose on grapefruit juice–triazolam interaction: repeated consumption prolongs triazolam half-life. Eur J Clin Pharmacol 2000; 56: 411–415.

    Article  CAS  Google Scholar 

  61. Weber A, Jager R, Borner A, et al. Can grapefruit juice influence ethinylestradiol bioavailability? Contraception 1996; 53: 41–47.

    Article  CAS  Google Scholar 

  62. Gross AS, Goh YD, Addison RS, Shenfield GM. Influence of grapefruit juice on cisapride pharmacokinetics. Clin Pharmacol Ther 1999; 65: 395–401.

    Article  CAS  Google Scholar 

  63. Kivisto KT, Lilja JJ, Backman JT, Neuvonen PJ. Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride. Clin Pharmacol Ther 1999; 66: 448–453.

    Article  CAS  Google Scholar 

  64. Offman EM, Freeman DJ, Dresser GK, Munoz C, Bend JR, Bailey DG. Red wine-cisapride interaction: comparison with grapefruit juice. Clin Pharmacol Ther 2001; 70: 17–23.

    Article  CAS  Google Scholar 

  65. Anonymous. Hismanal Product Monograph. Johnson and Johnson—Merck Consumer Pharmaceuticals of Canada. Guelph, Ontario, 1999.

    Google Scholar 

  66. Benton RE, Honig PK, Zamani K, Cantilena LR, Woosley RL. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin Pharmacol Ther 1996; 59: 383–388.

    Article  CAS  Google Scholar 

  67. Honig PK, Wortham DC, Lazarev A, Cantilena LR. Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J Clin Pharmacol 1996; 36: 345–351.

    Article  CAS  Google Scholar 

  68. Rau SE, Bend JR, Arnold JMO, Tran LT, Spence JD, Bailey DG. Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance. Clin Pharmacol Ther 1997; 61: 401–409.

    Article  CAS  Google Scholar 

  69. Clifford CP, Adams DA, Murray S et al. The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice. Eur J Clin Pharmacol 1997; 52: 311–315.

    Article  CAS  Google Scholar 

  70. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995; 57: 485–491.

    Article  CAS  Google Scholar 

  71. Yee GC, Stanley DL, Pessa JL, Costa TD, Beltz SE, Ruiz J, Lowenthal DT. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995; 345: 955–956.

    Article  CAS  Google Scholar 

  72. Ducharme MP, Provenzano R, Dehoorne-Smith M, Edwards DJ. Trough concentrations of cyclosporine following administration with grapefruit juice. Br J Clin Pharmacol 1993; 36: 457–459.

    Article  CAS  Google Scholar 

  73. Herlitz H, Edgar B, Hedner T, Lidman K, Karlberg I. Grapefruit juice: a possible source of variability in blood concentration of cyclosporin A (Letter). Nephrol Dial Transplant 1993; 8: 375.

    CAS  Google Scholar 

  74. Hollander AAMJ, van Rooij J, Lentjes EGWM, et al. The effect of grapefruit juice on cyclosporin and prednisone metabolism in transplant patients. Clin Pharmacol Ther 1995; 57: 318–324.

    Article  CAS  Google Scholar 

  75. Proppe DG, Hoch OD, McLean AJ, Visser KE. Influence of chronic ingestion of grapefruit juice on steady state blood concentrations of cyclosporine A in renal transplant patients with stable graft function. Br J Clin Pharmacol 1995; 39: 337.

    Article  CAS  Google Scholar 

  76. Min DI, Ku Y-M, Perry PJ, et al. Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. Transplantation 1996; 62: 123–125.

    Article  CAS  Google Scholar 

  77. Johnston A, Holt DW. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995; 346: 122–123.

    Article  CAS  Google Scholar 

  78. Westveer MK, Farquhar ML, George P, Mayers JT. Co-administration of grapefruit juice increases tacrolimus levels in liver transplant recipients. Ann Meet Am Soc Transplant Physicians 1996; 202: 115.

    Google Scholar 

  79. Fuhr U, Maier A, Keller A, Steinijans VW, Sauter R, Staib AH. Lacking effect of grapefruit juice on theophylline pharmacokinetics. Inter J Clin Pharmacol Ther 1995; 33: 311–314.

    CAS  Google Scholar 

  80. van Rooij J, van der Meer FJM, Schoemaker HC, Cohen AF. Comparison of the effect of grapefruit juice and cimetidine on pharmacokinetics and anticoagulant effect of a single dose of acenocoumarol (Abstract). Br J Clin Pharmacol 1993; 35: 548.

    Article  Google Scholar 

  81. Sullivan DM, Ford MA, Boyden TW. Grapefruit juice and the response to warfarin. Am J Health Syst Pharm 1998; 55: 1581–1583.

    CAS  Google Scholar 

  82. Demarles D, Gillotin C, Bonaventure-Paci S, Vincent I, Fosse S, Taburet AM. Single-dose pharmacokinetics of amprenavir coadministered with grapefruit juice. Antimicrob Agents Chemother 2002; 46: 1589–1590.

    Article  CAS  Google Scholar 

  83. Cheng KL, Nafziger AN, Peloquin CA, Amsden GW. Effect of grapefruit juice on clarithromycin pharmacokinetics. Antimicrob Agents Chemother 1998; 42: 927–929.

    CAS  Google Scholar 

  84. Shelton MJ, Wynn HE, Hewitt RG, DiFrancesco R. Effects of grapefruit juice on pharmacokinetic exposure to indinavir in HIV-positive subjects. J Clin Pharmacol 2001; 41: 435–442.

    Article  CAS  Google Scholar 

  85. Kawakami M, Suzuki K, Ishizuka T, Hidaka T, Matsuki Y, Nakamura H. Effect of grapefruit juice on pharmacokinetics of itraconazole in healthy subjects. Int J Clin Pharmacol Ther 1998; 36: 306–308.

    CAS  Google Scholar 

  86. Penzak SR, Gubbins PO, Gurley BJ, Wang PL, Saccente M. Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers. Ther Drug Monit 1999; 21: 304–309.

    Article  CAS  Google Scholar 

  87. Ho PC, Chalcroft SC, Coville PF, Wanwimolruk S. Grapefruit juice has no effect on quinine pharmacokinetics. Eur J Clin Pharmacol 1999; 55: 393–398.

    Article  CAS  Google Scholar 

  88. Josefsson M, Zackrisson AL, Ahlner J. Effect of grapefruit juice on the pharmacokinetics of aml odipine in healthy volunteers. Eur J Clin Pharmacol 1996; 51: 189–193.

    Article  CAS  Google Scholar 

  89. Vincent J, Harris SI, Foulds G, Dogolo LC, Willavize S, Friedman HL. Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine. Br J Clin Pharmacol 2000; 50: 455–463.

    Article  CAS  Google Scholar 

  90. Sigusch H, Henschel L, Kraul H, Merkel U, Hoffmann A. Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects. Pharmazie 1994; 49: 675–679.

    CAS  Google Scholar 

  91. Christensen H, Asberg A, Holmboe AB, Berg KJ. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers. Eur J Clin Pharmacol 2002; 58: 515–520.

    Article  CAS  Google Scholar 

  92. Munoz CE, Ito S, Bend JR, et al. Propafenone interaction with CYP3A4 inhibitors in man (Abstract). Clin Pharmacol Ther 1997; 61: 154.

    Google Scholar 

  93. Min DI, Ku Y-M, Geraets DR, Lee H-C. Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers. J Clin Pharmacol; 36: 469–476.

    Google Scholar 

  94. Damkier P, Hansen LL, Brosen K. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. Br J Clin Pharmacol 1999; 48: 829–838.

    Article  CAS  Google Scholar 

  95. Yasui N, Kondo T, Furukori H et al. Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam. Psychopharmacology 2000; 150: 185–190.

    Article  CAS  Google Scholar 

  96. Oesterheld J, Kallepalli BR. Grapefruit juice and clomipramine: shifting metabolic ratios (letter). J Clin Psychopharmacol 1997; 17: 62–63.

    Article  CAS  Google Scholar 

  97. Vandel S, Netillard C, Perault MC, Bel AM. Plasma levels of clozapine and desmethylclozapine are unaffected by concomitant ingestion of grapefruit juice. Eur J Clin Pharmacol 2000; 56: 347–348.

    Article  CAS  Google Scholar 

  98. Yasui N, Kondo T, Suzuki A, et al. Lack of significant pharmacokinetic interaction between haloperidol and grapefruit juice. Int Clin Psychopharmacol 1999; 14: 113–118.

    Article  CAS  Google Scholar 

  99. Kumar N, Garg SK, Prabhakar S. Lack of pharmacokinetic interaction between grapefruit juice and phenytoin in healthy male volunteers and epileptic patients. Methods Find Exp Clin Pharmacol 1999; 21: 629–632.

    CAS  Google Scholar 

  100. Schubert W, Cullberg G, Edgar B, Hedner T. Inhibition of 17b-estradiol metabolism by grapefruit juice in ovariectomized women. Maturitas 1994; 20: 155–163.

    Article  CAS  Google Scholar 

  101. Freedman MD, Somberg JC. Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol 1991; 31: 1061–1069.

    Article  CAS  Google Scholar 

  102. Fabre G, Julian B, Saint-Auber B, Joyeux H, Berger Y. Evidence of CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions. Drug Metab Dispos 1993; 21: 978–985.

    CAS  Google Scholar 

  103. Guentert TW, Holford N, Coates PE, Upton RA, Riegelman S. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies. J Pharmacokinet Biopharm 1979; 7: 315–330.

    Article  CAS  Google Scholar 

  104. Kessler KM, Lowenthal DT, Warner H, Gibson T, Briggs W. Quinidine elimination in patients with congestive heart failure or poor renal function. N Engl J Med 1974; 290: 706–709.

    Article  CAS  Google Scholar 

  105. Milton KA, Edwards G, Ward SA, Orme ML, Breckenridge AM. Pharmacokinetics of halofantrine in man: effects of food and dose size. Br J Clin Pharmacol 1989; 28: 71–77.

    Article  CAS  Google Scholar 

  106. Baune B, Flinois JP, Furlan V, et al. Halofantrine metabolism in microsomes in man: major role of CYP3A4 and CYP3A5. J Pharm Pharmacol 1999; 51: 419–426.

    Article  CAS  Google Scholar 

  107. Wesche DL, Schuster BG, Wang WX, Woosley RL. Mechanism of cardiotoxicity of halofantrine. Clin Pharmacol Ther 2000; 67: 521–529.

    Article  CAS  Google Scholar 

  108. Lea AP, McTavish D. Atorvastatin: a review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs 1997; 53: 828–847.

    Article  CAS  Google Scholar 

  109. Vickers S, Duncan CA, Chen IW, Rosegay A, Duggan DE. Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug. Drug Metab Dispos 1990; 18: 138–145.

    CAS  Google Scholar 

  110. Laitinen T, Hartikainen J, Vanninen E, Niskanen L, Geelen G, Lansimies E. Age and gender dependency of sensitivity in healthy subjects. J Appl Physiol 1998; 84: 576–583.

    CAS  Google Scholar 

  111. Landahl S, Edgar B, Gabrielsson M, et al. Pharmacokinetics and blood pressure effects of felodipine in elderly hypertensive patients. A comparison with young healthy subjects. Clin Pharmacokinet 1998; 14: 374–383.

    Article  Google Scholar 

  112. Walker DK, Ackland MJ, James GC, et al. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica 1999; 29: 297–310.

    Article  CAS  Google Scholar 

  113. Warrington JS, Shader RI, von Moltke LL, Greenblatt DJ. In vitro biotransformations of sildenafil (Viagra): identification of human cytochromes and potential drug interactions. Drug Metab Dispos 2000; 28: 392–397.

    CAS  Google Scholar 

  114. Zaidenstein R, Soback S, Gips M, Avni B, Dishi V, Weissgarten Y, Golik A, Scapa E. Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers. Ther Drug Monit 2001; 23: 369–373.

    Article  CAS  Google Scholar 

  115. van Agtmael MA, Gupta V, van der Graaf CA, can Boxtel CJ. The effect of grapefruit juice on the time-dependent decline of artemether plasma levels in healthy subjects. Clin Pharmacol Ther 1999; 66: 408–414.

    Article  Google Scholar 

  116. Merry C, Barry MG, Mulcahy F, et al. Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS 1997; 11: F29 - F33.

    Article  CAS  Google Scholar 

  117. Lau WC, Waskell LA, Watkins PB, et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation 2003; 107: 32–37.

    Article  CAS  Google Scholar 

  118. Sanders SW, Haering N, Mosberg H, et al. Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing. Eur J Clin Pharmacol 1986; 30: 331–334.

    Article  CAS  Google Scholar 

  119. Anonymous. New contraindications for medications containing ergotamine and dihydroergotamine. Health Canada. Health Products and Food Branch. February 2003.

    Google Scholar 

  120. Duvelleroy Hommet C, Jonville-Bera AP, Autret A, Saudeau D, Autret E, Fauchier JP. Convulsive seizures in a patient treated with propafenone and ketoconazole. Therapie 1995; 50: 164–165.

    CAS  Google Scholar 

  121. Niemi M, Neuvonen PJ, Kivisto KT. The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide. Clin Pharmacol Ther 2001; 70: 58–65.

    Article  CAS  Google Scholar 

  122. Anonymous. Sibutramine Product Monograph 2002. Abbott Laboratories Limited, Saint-Laurent, Quebec.

    Google Scholar 

  123. Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH, et al. 6’,7’- Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 1999; 65: 237–244.

    Article  CAS  Google Scholar 

  124. Becquemont L, Verstuyft C, Kerb R, Brinkmann U, Lebot M, Jaillon P, Funck-Brentano C. Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin Pharmacol Ther 2001; 70: 311–316.

    CAS  Google Scholar 

  125. Spahn-Langguth H, Langguth P. Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur J Pharm Sci 2001; 12: 316–317.

    Article  Google Scholar 

  126. Tian R, Koyabu N, Takanaga H, Matuso H, Ohtani H, Sawada Y. Effects of grapefruit on the intestinal efflux of P-glycoprotein substrates. Pharm Res 2002: 19: 802–809.

    Article  CAS  Google Scholar 

  127. Takanaga H, Ohnishi A, Matsuo H, Sawada Y. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in Caco-2 cells. Biol Pharm Bull 1998; 21: 1062–1066.

    Article  CAS  Google Scholar 

  128. Soldner A, Christians U, Susanto M, Wacher VJ, Silverman JA, Benet LZ. Grapefruit juice activates P-glycoprotein-mediated drug transport. Pharm Res 1999; 16: 478–485.

    Article  CAS  Google Scholar 

  129. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther. 2002; 71: 11–20.

    Article  CAS  Google Scholar 

  130. Reif S, Nicolson MC, Bisset D, Reid M, Kloft C, Jaehde U, McLeod HL. Effect of grapefruit juice intake on etoposide bioavailability. Eur J Clin Pharmacol. 2002; 58: 491–494.

    Article  CAS  Google Scholar 

  131. Lilja JJ, Backman JT, Laitila J, Luurila H, Neuvonen PJ. Itraconazole increases but grapefruit juice decreases plasma concentrations of celiprolol. Clin Pharmacol Ther 2003; 73: 192–198.

    Article  CAS  Google Scholar 

  132. Leenen, F.H.H., Logan, A.G., Myers, M.G., Elkan, I. The Canadian Felodipine Study Group. Anti-hypertensive efficacy of the calcium antagonist felodipine in patients remaining hypertensive on betaadrenoceptor blocker therapy. Br J Clin Pharmacol 1988; 26: 535–545.

    Article  Google Scholar 

Download references

Authors
  1. David G. Bailey
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacy Practice, Temple University School of Pharmacy, Philadelphia, PA, USA

    Joseph I. Boullata PharmD, BCNSP

  2. Department of Surgery, Temple University School of Medicine, Philadelphia, PA, USA

    Vincent T. Armenti MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bailey, D.G. (2004). Grapefruit Juice-Drug Interaction Issues. In: Boullata, J.I., Armenti, V.T. (eds) Handbook of Drug-Nutrient Interactions. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-781-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-781-9_9

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5359-2

  • Online ISBN: 978-1-59259-781-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation